FDA Approves VALPROIC ACID — ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. announced FDA approval of its oral Valproic Acid generic (ANDA073178), a development that further diversifies the company's product portfolio and strengthens its competitive position within the established generics market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day